Necessity for and Limitations of Price Transparency in American Health Care
Author:
Open Access
- 1 November 2022
- journal article
- research article
- Published by American Medical Association (AMA) in AMA Journal of Ethics
- Vol. 24 (11) , E1069-1074
Abstract
Price transparency is an ethical and policy imperative for American health care. More transparent pricing would allow patients and families to make better decisions and would allow clinicians to deliver care with greater simplicity and integrity. This article also considers transparency’s real-world patient care limitations and the extent to which price transparency is a reliable pathway to service delivery efficiency and market discipline.Keywords
This publication has 10 references indexed in Scilit:
- Evaluation of a computerized contraceptive decision aid: A randomized controlled trialContraception, 2020
- Association of Diagnosis Coding With Differences in Risk-Adjusted Short-term Mortality Between Critical Access and Non–Critical Access HospitalsJAMA, 2020
- Improving Cancer Patients’ Insurance Choices (I Can PIC): A Randomized Trial of a Personalized Health Insurance Decision AidThe Oncologist, 2020
- Consumer Response to Composite Ratings of Nursing Home QualityAmerican Journal of Health Economics, 2019
- Are Health Care Services Shoppable? Evidence from the Consumption of Lower-Limb MRI Scans2018
- What does a Deductible Do? The Impact of Cost-Sharing on Health Care Prices, Quantities, and Spending Dynamics*The Quarterly Journal of Economics, 2017
- Nursing Home 5-Star Rating System Exacerbates Disparities In Quality, By Payer SourceHealth Affairs, 2015
- Upcoding: Evidence from Medicare on Squishy Risk Adjustment2015
- Auditing Access to Specialty Care for Children with Public InsuranceNew England Journal of Medicine, 2011
- Government‐Assisted Oligopoly Coordination? A Concrete CaseThe Journal of Industrial Economics, 1997